z-logo
open-access-imgOpen Access
Inhibition of inositol kinase B controls acute and chronic graft-versus-host disease
Author(s) -
Govindarajan Thangavelu,
Jing Du,
Katelyn Paz,
Michaël Loschi,
Michael Zaiken,
Ryan Flynn,
Patricia A. Taylor,
Andrew Kemal Kirchmeier,
Angela PanoskaltsisMortari,
Leo Luznik,
Kelli P. A. MacDonald,
Geoffrey R. Hill,
Ivan Maillard,
David H. Munn,
Jonathan S. Serody,
William J. Murphy,
David B. Miklos,
Corey Cutler,
John Koreth,
Joseph H. Antin,
Robert J. Soiffer,
Jerome Ritz,
Carol Dahlberg,
Andrew T. Miller,
Bruce R. Blazar
Publication year - 2019
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood.2019000032
Subject(s) - immunology , graft versus host disease , cancer research , t cell , pathogenesis , myeloid leukemia , biology , medicine , microbiology and biotechnology , immune system , stem cell
T-cell activation leads to regulated increases in cytoplasmic calcium through inositol 1,4,5-triphosphate (IP3), a process balanced by phosphorylation and inactivation of IP3 by inositol 1,4,5-trisphosphate 3-kinase B (Itpkb). The investigators demonstrate that inhibition of Itpkb sustains increased intracellular Ca, leads to T-cell apoptosis, and inhibits graft-versus-host disease without impairing graft-versus-leukemia effects.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom